Fecal microbiota transplant (FMT) for the treatment of Clostridium difficile infection in immunocompromised patients is safe and effective, according to a study in the American Journal of Gastroenterology. Read more and read an American Nurse Today article on FMT https://www.myamericannurse.com/fecal-microbiota-transplantation-breaking-the-chain-of-recurrent-c-difficile-infection/.
Study: Fecal microbiota transplant effective in immunocompromised patients
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
